Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status:
Terminated
Trial end date:
2020-06-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential of DFD-06 to suppress the
hypothalamic-pituitary-adrenal (HPA) axis when applied twice daily for 15 days.